Wordt geladen...
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial
AIMS: The primary aim of the CANagliflozin cardioVascular Assessment Study‐Renal (CANVAS‐R) is to determine whether the favourable effects of inhibition of the sodium glucose co‐transporter 2 (SGLT2) on blood glucose, blood pressure and body weight are accompanied by protection against adverse renal...
Bewaard in:
| Gepubliceerd in: | Diabetes Obes Metab |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Blackwell Publishing Ltd
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348724/ https://ncbi.nlm.nih.gov/pubmed/28120497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12829 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|